Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Intranasal Ketamine (IN)
DRUG
2 trials
Sponsors
Centre for Addiction and Mental Health
, Fondation Lenval
Conditions
Acute Pain
Analgesia
Depression
Fractures Bone
Pain
Pain Management
Traumatology
Wounds and Injury
Phase 2
Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.
Not yet recruiting
NCT06968546
Fondation Lenval
Acute Pain, Analgesia, Fractures Bone +4
Start: 2026-02-05
End: 2028-03-31
Target: 116
Updated: 2026-01-28
Unknown Phase
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Completed
NCT05137938
Centre for Addiction and Mental Health
Depression
Start: 2021-10-25
End: 2023-07-24
Updated: 2023-08-14
Related Papers
Intranasal sufentanil versus ketamine for acute severe traumatic pain in children: protocol for a phase II randomised controlled trial (SUF-KET-PED).
2026-05-20
The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial
JMIR Research Protocols
2021-12-08
3 citations